The global infectious respiratory disease diagnostics market size is calculated at USD 57.55 billion in 2025 and is forecasted to reach around USD 91.91 billion by 2034, accelerating at a CAGR of 5.34% from 2025 to 2034. The North America infectious respiratory disease diagnostics market size surpassed USD 22.94 billion in 2024 and is expanding at a CAGR of 5.46% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Infectious Respiratory Disease Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Product Type
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast
8.1.3. Services
8.1.3.1. Market Revenue and Forecast
9.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Sample Type
9.1.1. Saliva
9.1.1.1. Market Revenue and Forecast
9.1.2. Nasopharyngeal Swabs (NPS)
9.1.2.1. Market Revenue and Forecast
9.1.3. Anterior Nasal Region
9.1.3.1. Market Revenue and Forecast
9.1.4. Blood
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Application
10.1.1. COVID-19
10.1.1.1. Market Revenue and Forecast
10.1.2. Influenza
10.1.2.1. Market Revenue and Forecast
10.1.3. RSV (Respiratory Syncytial Virus)
10.1.3.1. Market Revenue and Forecast
10.1.4. Tuberculosis
10.1.4.1. Market Revenue and Forecast
10.1.5. Streptococcus Testing
10.1.5.1. Market Revenue and Forecast
10.1.6. Other
10.1.6.1. Market Revenue and Forecast
11.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Technology
11.1.1. Immunoassay
11.1.1.1. Market Revenue and Forecast
11.1.2. Molecular Diagnostics
11.1.2.1. Market Revenue and Forecast
11.1.3. Microbiology
11.1.3.1. Market Revenue and Forecast
11.1.4. Other
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type
12.1.2. Market Revenue and Forecast, by Sample Type
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by Technology
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type
12.1.5.2. Market Revenue and Forecast, by Sample Type
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by Technology
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type
12.1.6.2. Market Revenue and Forecast, by Sample Type
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by Technology
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type
12.2.2. Market Revenue and Forecast, by Sample Type
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by Technology
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type
12.2.5.2. Market Revenue and Forecast, by Sample Type
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by Technology
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type
12.2.6.2. Market Revenue and Forecast, by Sample Type
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by Technology
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type
12.2.7.2. Market Revenue and Forecast, by Sample Type
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by Technology
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type
12.2.8.2. Market Revenue and Forecast, by Sample Type
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by Technology
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type
12.3.2. Market Revenue and Forecast, by Sample Type
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by Technology
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type
12.3.5.2. Market Revenue and Forecast, by Sample Type
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by Technology
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type
12.3.6.2. Market Revenue and Forecast, by Sample Type
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by Technology
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type
12.3.7.2. Market Revenue and Forecast, by Sample Type
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by Technology
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type
12.3.8.2. Market Revenue and Forecast, by Sample Type
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by Technology
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type
12.4.2. Market Revenue and Forecast, by Sample Type
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by Technology
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type
12.4.5.2. Market Revenue and Forecast, by Sample Type
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by Technology
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type
12.4.6.2. Market Revenue and Forecast, by Sample Type
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by Technology
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type
12.4.7.2. Market Revenue and Forecast, by Sample Type
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by Technology
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type
12.4.8.2. Market Revenue and Forecast, by Sample Type
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by Technology
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type
12.5.2. Market Revenue and Forecast, by Sample Type
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by Technology
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type
12.5.5.2. Market Revenue and Forecast, by Sample Type
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by Technology
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type
12.5.6.2. Market Revenue and Forecast, by Sample Type
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by Technology
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abbott Laboratories
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Becton, Dickinson and Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. QIAGEN N.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bio-Rad Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cepheid (Danaher Corporation)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Hologic, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Luminex Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample